阿司匹林治疗脑梗死患儿的研究进展  

Research progress on aspirin in treatment of child patients with cerebral infarction

作　　者：曾兆禄[1] 蒋喜凤[2] ZENG Zhao-lu;JIANG Xi-feng(Department of Acupuncture,the People’s Hospital of Linqu,Weifang 262600,China;Department of Pediatrics,Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine,Nanning 550003,China)

机构地区：[1]临朐县人民医院针灸科,山东潍坊262600 [2]广西中医药大学附属瑞康医院儿科,广西南宁550003

出　　处：《现代药物与临床》2020年第3期591-596,共6页Drugs & Clinic

摘　　要：尽管阿司匹林是预防和治疗儿童脑梗死的常用药,但目前尚无统一的给药方案或指南。提供了阿司匹林治疗脑梗死患儿的一些临床证据,并总结了妨碍阿司匹林疗效的常见因素以及相关的常见不良反应,建议迫切需要大规模的儿科临床试验来规范阿司匹林的使用。Although aspirin is often used to prevent and manage cerebral infarction of child patients, by now there is no regular protocols or guidelines for the administration. The clinical evidence of aspirin in treatment of child patients with cerebral infarction and common situations or factors which may limit its efficacy and some adverse effects related to aspirin administered to pediatric patients are reviewed in this paper. Finally it is necessary to perform prospective clinical study on pediatric cerebral infarction to standardize the use of aspirin in the pediatric clinics.

关 键 词：阿司匹林 患儿 脑梗死 

分 类 号：R971[医药卫生—药品] R985[医药卫生—药学]